| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |